Cardiac involvement was observed in 6/60 patients (10.0%), presenting as cardiac troponin I (cTnI) elevation, myocardial ischemia, arrhythmia, or myocardial MRI that demonstrated myocardial fibrosis. This evidence concerns the gene TNNI3 and Myocardial fibrosis.